Effect of partial volume correction on muscarinic cholinergic receptor imaging with single-photon emission tomography in patients with temporal lobe epilepsy

European Journal of Nuclear Medicine

Volumn 24, Issue 9, 1997, Pages 1156-1161

  Weckesser, Matthias ^a   Hufnagel, Andreas ^b   Ziemons, Karl ^a   Grießmeier, Martin ^a   Sonnenberg, Frank ^a   Hackländer, Thomas ^c   Langen, Karl J ^a   Holschbach, Markus ^a   Elger, Christian E ^b   Müller Gärtner, Hans W ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cholinergic system; Emission tomography; Epilepsy; Muscarinic receptors

Indexed keywords

ACETYLCHOLINE; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RECEPTOR DENSITY; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE EPILEPSY;

EID: 9844266784     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01254249     Document Type: Article

References (29)

1. Davis KL, Mohs RC, Tinklenberg JR, Pfefferbaum A, Hollister LE, Koppel BS. Physostigmine: improvement of long-term memory processes in normal humans. Science 1978; 201: 272-274.
2. Sitarum H, Weingartner JC, Gillin H. Human serial learning: enhancement with arecholine and choline and impairment with scopolamine. Science 1978; 201: 274-276.
3. Bartus RL, Dean RL III, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408-417.
4. Aarsland D, Larsen P, Reinvang I, Aasland AM. Effects of cholinergic blockade on language in healthy young women: implications for the cholinergic hypothesis in dementia of the Alzheimer type. Brain 1994; 117: 1377-1384.
5. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215: 1237-1239.
6. Holman BL, Gibson RE, Hill TC, Eckelman WC, Albert M, Reba RC. Muscarinic acetycholine receptors in Alzheimer's disease. JAMA 1985; 254: 3063-3066.
7. Quirion R, Aubert P, Lapchak A, Schaum RP, Teolis S, Gauthier S, Araujo DM. Muscarinic receptor subtypes in neurodegenerative disorders: focus on Alzheimer's disease. Trends Pharmacol Sci 1989 Suppl: 80-84.
8. Wurtmann RJ. The return of the cholinergic hypothesis. J Clin Invest 1994; 94: 470.
9. MacNamara JO. Muscarinic cholinergic receptors participate in the kindling model of epilepsy. Brain Res 1978; 154: 415-420.
10. Dasheiff RM, Savage DD, McNamara JO. Seizures down-regulate muscarinic cholinergic receptors in hippocampal formation. Brain Res 1981; 235: 327-334.
11. Liles WC, Taylor S, Finnel R, Lai H, Nathanson NM. Decreased muscarinic acetylcholine receptor number in the central nervous system of the tottering mouse. J Neurochemistry 1986; 46: 977-982.
12. Cruikshank JW, Brudzynski SM, McLachlan RS. Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in rat brain. Brain Res 1994; 643: 125-129.
13. Danober L, Vergnes M, Depaulis A, Marescaux C. Nucleus basalis lesions suppress spike and wave discharges in rats with spontaneous absence-epilepsy. Neuroscience 1994; 59: 531-539.
14. 123I-iododexetimide and single photon emission computer tomography in epilepsy. Ann Neurol 1993; 34: 235-238.
15. Boundy KL, Rowe CC, Black AB, Kitchener MI, Barnden LR, Sebben R, Kneebone MA, Kassiou M, Katsifis A, Lambrecht R. Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography. Neurology 1996; 47: 1015-1020.
16. 123I]4-iododexetimide, a potent muscarinic cholinergic receptor antagonist. J Med Chem 1989; 32: 1057-1062.
17. 123I]4-iodolevetimide. J Cereb Blood Flow Metab 1992; 12: 562-570.
18. Glover G, Pele N. The nonlinear partial volume artefact. J Comput Assist Tomogr 1979; 3: 573-574.
19. Kojima A, Matsumoto M, Takahashi M, Hirota Y, Yoshida H. Effect of spatial resolution on SPECT quantification values. J Nucl Med 1989; 30: 508-514.
20. Jack CR, Sharbrough FW, Twomey CK, Zinsmeister AR. Temporal lobe seizures: lateralisation with MR volume measurements of hippocampal formation. Radiology 1990; 175: 423-429.
21. Jack CR, Sharbrough FW, Cascino GD, Hirschorn KA, O'Brian PC, Marsh WR. Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol 1992; 31: 138-146.
22. vanPaesschen W, Sisodiya S, Connelly A, Duncan JS, Free SL, Raymond AA, Grunewald RA, Revesz T. Quantitative hippocampal MRI and intractable temporal-lobe epilepsy. Neurology 1995; 45: 2233-2240.
23. Savic I, Roland P, Sedvall G, Persson A, Pauli S, Widen L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 1988: II: 863-866.
24. 123I-Iomazenil SPECT. Acta Neurochir Suppl. (Wien) 1990; 50: 95-99.
25. Burdette DE, Sakurai SY, Henry TR, Ross DA, Pennell PB, Frey KA, Sackellares JC, Albin RL. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology 1995; 45: 934-941.
26. Behrens E, Zentner J, van Roost D, Hufnagel A, Elger CE, Schramm J. Subdural and depth electrodes in the presurgical evaluation of epilepsy. Acta Neurochir (Wien) 1994; 128: 84-87.
27. Hufnagel A, Burr W, Elger CE, Nadstawek J, Hefner G. Localisation of the epileptogenic focus during methohexital induced anaesthesia. Epilepsia 1992; 33: 271-284.
28. Hufnagel A, Elger CE, Pels H, Zentner J, Wolf H, Schramm J, Wiestler OD. Prognostic significance of ictal and interictal epileptiform activity in temporal lobe epilepsy. Epilepsia 1995; 35: 1146-1153.
29. Hufnagel A, Poersch M, Elger CE, Zentner J, Wolf H, Schramm J. The clinical and prognostic relevance of the postictal slow focus in the electrocorticogram. Electroencephalogr Clin Neurophysiol 1995; 94: 12-18.